Lung Cancer
Volume 45, Supplement 2 , Pages S13-S19, August 2004

Impact of low-dose CT on lung cancer screening

  • Stefan Diederich

      Affiliations

    • Department of Diagnostic and Interventional Radiology, Marien-Hospital Düβeldorf, Rochuβtr. 2, D-40479 Dβeldorf, Germany
    • Corresponding Author InformationCorrespondence to: Prof. Dr. med. Stefan Diederich, Dept. of Diagnostic and Interventional Radiology and Nuclear Medicine, Marien-Hospital, Rochuβtraße 2, D-40479 Düβeldorf, Germany. Tel: +49-(211)-4400-2101; fax: +49-(211)-4400-2102.
  • ,
  • Dag Wormanns

      Affiliations

    • Department of Clinical Radiology, University Hospital Münster, Albert-Schweitzer-Str. 33, D-48149 Münster, Germany

Summary 

Despite advances in therapy, the prognosis of lung cancer remains dismal due to the fact that most cases of lung cancer are diagnosed at advanced stages, when the chance of cure is poor. In cases detected at early stages prognosis is better. Unfortunately, early lung cancer usually causes no symptoms and is, consequently, rarely diagnosed.

Therefore, screening for early asymptomatic lung cancer with diagnostic procedures appears promising particularly as risk factors for lung cancer are well known (cigarette smoking, occupational asbestos exposure and others) and screening could, therefore, focus on these risk groups.

In the past, screening trials using analysis of sputum cytology and to some extent chest radiography have failed to demonstrate a reduction in lung-cancer mortality with screening, probably due to insufficient sensitivity of these tests for early lung cancer. During the last decade the introduction of spiral computed tomography (CT) has provided a technique with a much higher sensitivity for small lung cancers.

Feasibility studies using low-radiation-dose CT demonstrated a high proportion of non-small-cell lung cancer at the initial examination (prevalence) with decreasing numbers of detected cancers at follow-up (incidence). The proportion of early-stage tumors was high both at prevalence and incidence examinations. The rate of invasive procedures for benign lesions was low; most indeterminate lesions could be classified with non-invasive diagnostic approaches. The proportion of interval cancers (cancers diagnosed by symptoms between two screening CT scans) was low. As, however, these one-arm feasibility trials are not appropriate to ass; a potential mortality reduction through CT screening, prospective randomised multicenter trials were recently initiated in several countries to analyse the effect of CT screening on lung-cancer mortality.

Lung cancer, Pulmonary nodule, Follow-up, Volumetry, Contrast-enhanced CT, Radiation exposure

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0169-5002(04)80003-5

doi:10.1016/j.lungcan.2004.07.997

Lung Cancer
Volume 45, Supplement 2 , Pages S13-S19, August 2004